Clinical Trials
Lawley Pharmaceuticals is continually engaged in the process of developing and testing new treatment options in its selected therapeutic areas of men’s and women’s health. Specific areas of interest include andrology, gynaecology, urology and endocrinology.
Studies under way which are currently recruiting patients include:
The Pharmacokinetics of AndroForte® Compared With AndroGel® (Testogel®) in Androgen Deficient Men
Status: Recruiting in NSW and Victoria. For more information click here.
The Role of Testosterone on Aβ Deposition of Alzheimer’s disease
Status: Recruiting in Western Australia and Indonesia. For more information please click here.
Completed clinical studies by Lawley Pharmaceuticals include:
- The effectiveness of transdermal progesterone cream on menopausal symptoms, lipids and bone markers.
- The effects of sequential transdermal progesterone cream on endometrium bleeding pattern and salivary levels in post-menopausal women.
- Evaluation of serum testosterone levels after topical applications of AndroFeme® cream in post menopausal women with symptoms of testosterone deficiency.
- Systemic absorption after transdermal application of labelled Progesterone in Rats.
- Plasma and saliva concentrations of progesterone in pre- and postmenopausal women after topical application of progesterone cream.
- Pharmacokinetics of AndroForte® 5%: A dose-finding clinical trial.
- Long-Term pharmacokinetics and clinical efficacy of AndroForte® 5% cream for androgen replacement in hypogonadal men.
- Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
- A double blind, randomized trial of the effect of testosterone cream on the sexual motivation of menopausal women with poor libido
- A pharmacokinetic study of the half-life of topical testosterone cream from a single application and after daily application.